Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The ruling centered on PrEP as HIV prevention but could apply to cancer screenings and other services and drugs.
Insurers should allow co-pay assistance to count as out-of-pocket spending, claims HHS lawsuit by HIV, hepatitis and diabetes advocates.
Over 80% of surveyed cancer patients say copay assistance programs helped them afford medications. But there’s a downside too.
Some 100 million people—including 41% of U.S. adults—have health care debt, according to a recent KFF survey.
A letter from 124 patient groups urges the White House to make drugs more affordable—and spells out how it can do so.
During the COVID-19 crisis, some insurers are relaxing their refill rules and allowing 90-day supplies of meds to be prescribed.
Over 60 drugmakers raised prices an average of 5.8% on hundreds of drugs.
Insurance companies can no longer implement harmful co-pay accumulator policies.
Stop me if you’ve heard this one before.
The patient advocacy coalition I Am Essential sent a letter to the HHS spelling out why the plan is dangerous.
Health coalition warns the federal government: People with chronic or serious conditions face growing costs at the pharmacy.
JAMA study says laws designed to equalize out-of-pocket costs faced by cancer patients undergoing chemotherapy are having mixed results
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.